FDA Inspection 833939 — Jeffrey G. Leflein, M.D.
The FDA completed an inspection of Jeffrey G. Leflein, M.D. on May 14, 2013 in Ypsilanti, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 14, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Ypsilanti, MI (United States)
Additional Details
Clinical Investigator (CI)